Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.02 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | -18,108,736.66 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | N/A |
| ROE (TTM) | -106,268,225,620.78% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 81,414.68% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 81,444.26% | N/A | N/A |
| Cash Flow | -30,620,072.75% | N/A | N/A |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.52 | N/A |
| Quick Ratio (TTM) | 1.52 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 0.00 | N/A |
| Piotroski F-Score | N/A | N/A |
| Altman Z-Score | 7.25 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |